Echocardiographic tissue imaging evaluation of myocardial characteristics and function in cardiomyopathies

Area of Science:

• Cardiology
• Medical Imaging
• Ultrasound Technology

Background:

• Cardiomyopathies significantly impact cardiac structure and function.
• Echocardiographic tissue imaging (ETI) parameters are crucial for evaluating and managing cardiomyopathies.
• Myocardial function is generally impaired across various cardiomyopathies, notably in non-ischemic dilated cardiomyopathy (DCM).

Purpose of the Study:

• To review the utility of echocardiographic tissue imaging (ETI) and other ultrasound techniques in detecting cardiomyopathies.
• To focus on the clinical and subclinical characteristics of DCM, hypertrophic cardiomyopathy (HCM), and cardiac amyloidosis.
• To highlight ETI's role in diagnosing and managing specific cardiomyopathies.

Main Methods:

• Review of current echocardiography techniques, including tissue Doppler, strain, and strain rate.
• Analysis of ETI's application in diagnosing and managing DCM, HCM, and cardiac amyloidosis.
• Comparison of ETI findings with other imaging modalities like cardiac magnetic resonance imaging.

Main Results:

• ETI demonstrates depressed myocardial function in cardiomyopathies, especially DCM.
• ETI aids in identifying subclinical HCM, differentiating it from other hypertrophic conditions, and predicting events.
• ETI reveals specific findings in cardiac amyloidosis, such as "apical sparing," and assesses left ventricular outflow tract obstruction in HCM.

Conclusions:

• ETI is a valuable tool for assessing cardiac structure and function in cardiomyopathies.
• ETI provides unique insights into HCM and cardiac amyloidosis, aiding diagnosis and management.
• While effective, ETI's histological detail is less comprehensive than cardiac MRI.